The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Dsuvia
Sufentanil · SUFENTANIL 30 ug/1 · Tablet · Sublingual · AcelRx Pharmaceuticals, Inc.
NDC 61621-0430-01 · 1 TABLET in 1 POUCH · NDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Estimated fill cost
WAC per package, as filed
$79.99
Reported to Texas DSHS · 2025 annual filing · Vertical Pharmaceuticals
Manufacturer list price as filed — not what pharmacies actually pay after discounts.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Is this a "specialty" drug?
There's no legal definition — it meets 1 of 6 public criteria. Why that matters →
- Part D specialty tier
- Costs ≥ $950/fill
- Biologic (BLA)
- Injectable / infused
- Orphan-drug exclusivity
- REMS program · Dsuvia
Regulatory
- Application
- NDA209128
- TE code
- —
- Approval date
- Nov 2, 2018
- Patents / exclusivity
- 21 patents, 0 exclusivities
| Type | Number / code | Expires |
|---|---|---|
| patent | 11672738 | Feb 2, 2038 |
| patent | 8945592 | Jul 29, 2031 |
| patent | 8202535 | Oct 22, 2030 |
| patent | 8865743 | Oct 22, 2030 |
| patent | 8574189 | Mar 16, 2030 |
| patent | 12033733 | Mar 16, 2030 |
| patent | 11676691 | Mar 16, 2030 |
| patent | 10896751 | Mar 16, 2030 |
| patent | 9744129 | Jan 5, 2027 |
| patent | 8252329 | Jan 5, 2027 |
| patent | 10342762 | Jan 5, 2027 |
| patent | 8252328 | Jan 5, 2027 |
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Sufentanil (Tablet)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Patheon Pharmaceuticals Inc. | SUFENTANIL 30 ug/1 | Jul 15, 2026 | Sep 2, 2026 |
| AcelRx Pharmaceuticals, Inc. | SUFENTANIL 30 ug/1 | Jul 15, 2026 | Jul 29, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Dsuvia — NDC 61621-0430-01," retrieved September 3, 2026, https://drugdashboards.com/drug/61621043001.
Free to cite with attribution — see how the data is put together.